Charles River Laboratories Other Long-Term Assets 2010-2024 | CRL

Charles River Laboratories other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Charles River Laboratories other long-term assets for the quarter ending September 30, 2024 were $0.307B, a 98.23% increase year-over-year.
  • Charles River Laboratories other long-term assets for 2023 were $0.309B, a 108.65% increase from 2022.
  • Charles River Laboratories other long-term assets for 2022 were $0.148B, a 2.15% decline from 2021.
  • Charles River Laboratories other long-term assets for 2021 were $0.152B, a 85.89% decline from 2020.
Charles River Laboratories Annual Other Long-Term Assets
(Millions of US $)
2023 $309
2022 $148
2021 $152
2020 $1,074
2019 $826
2018 $682
2017 $426
2016 $409
2015 $285
2014 $234
2013 $62
2012 $49
2011 $58
2010 $62
2009 $53
Charles River Laboratories Quarterly Other Long-Term Assets
(Millions of US $)
2024-09-30 $307
2024-06-30 $301
2024-03-31 $303
2023-12-31 $309
2023-09-30 $155
2023-06-30 $155
2023-03-31 $154
2022-12-31 $148
2022-09-30 $1,340
2022-06-30 $1,401
2022-03-31 $1,305
2021-12-31 $152
2021-09-30 $1,354
2021-06-30 $1,322
2021-03-31 $1,062
2020-12-31 $1,074
2020-09-30 $980
2020-06-30 $957
2020-03-31 $950
2019-12-31 $826
2019-09-30 $814
2019-06-30 $827
2019-03-31 $683
2018-12-31 $682
2018-09-30 $700
2018-06-30 $703
2018-03-31 $441
2017-12-31 $426
2017-09-30 $414
2017-06-30 $400
2017-03-31 $393
2016-12-31 $409
2016-09-30 $405
2016-06-30 $418
2016-03-31 $279
2015-12-31 $285
2015-09-30 $66
2015-06-30 $63
2015-03-31 $71
2014-12-31 $234
2014-09-30 $84
2014-06-30 $82
2014-03-31 $64
2013-12-31 $62
2013-09-30 $57
2013-06-30 $54
2013-03-31 $49
2012-12-31 $49
2012-09-30 $41
2012-06-30 $41
2012-03-31 $47
2011-12-31 $58
2011-09-30 $57
2011-06-30 $56
2011-03-31 $65
2010-12-31 $62
2010-09-30 $65
2010-06-30 $53
2010-03-31 $54
2009-12-31 $53
2009-09-30 $53
2009-06-30 $61
2009-03-31 $51
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00